GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 126 filers reported holding GENOMIC HEALTH INC in Q1 2017. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $818,000 | -78.6% | 12,063 | -81.7% | 0.24% | -71.9% |
| Q2 2019 | $3,825,000 | +72.4% | 65,753 | +107.6% | 0.87% | +75.4% |
| Q1 2019 | $2,219,000 | +9.9% | 31,677 | +1.0% | 0.50% | +1.2% |
| Q4 2018 | $2,020,000 | -45.2% | 31,359 | -40.3% | 0.49% | -28.6% |
| Q3 2018 | $3,687,000 | +1.1% | 52,508 | -27.4% | 0.68% | -2.8% |
| Q2 2018 | $3,646,000 | +44.1% | 72,340 | -10.6% | 0.70% | +49.7% |
| Q1 2018 | $2,531,000 | -19.8% | 80,903 | -12.3% | 0.47% | -28.1% |
| Q4 2017 | $3,156,000 | +19.2% | 92,279 | +11.8% | 0.66% | -11.2% |
| Q3 2017 | $2,648,000 | +1.5% | 82,503 | +3.0% | 0.74% | -4.3% |
| Q2 2017 | $2,608,000 | +3.9% | 80,135 | +0.6% | 0.77% | +23.0% |
| Q1 2017 | $2,510,000 | – | 79,693 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 13,668,866 | $353,955,000 | 3.71% |
| Camber Capital Management LP | 2,458,100 | $63,652,000 | 3.08% |
| Ghost Tree Capital, LLC | 200,000 | $5,179,000 | 1.50% |
| Tributary Capital Management, LLC | 206,291 | $5,342,000 | 0.78% |
| Motley Fool Asset Management LLC | 131,935 | $3,416,000 | 0.74% |
| CORRADO ADVISORS, LLC | 40,695 | $1,054,000 | 0.68% |
| Broadfin Capital, LLC | 270,400 | $7,002,000 | 0.68% |
| ACUTA CAPITAL PARTNERS, LLC | 48,800 | $1,264,000 | 0.61% |
| Motley Fool Wealth Management, LLC | 123,018 | $3,186,000 | 0.35% |
| TFS CAPITAL LLC | 61,773 | $1,600,000 | 0.29% |